Clinical trial
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
NCT06195306
Study timeline
Study start (actual)2025-07-28Date precision: day
Registry last updated2026-08-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Atypical Hyperplasiaunresolved
Breast Carcinomaunresolved
Breast Ductal Carcinoma In Situunresolved
Breast Lobular Carcinoma In Situunresolved
Interventions
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06195306 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.